Menu

 

Letter

Small risk ratios may have strong public health impact

BMJ 2003; 327 doi: http://dx.doi.org/10.1136/bmj.327.7422.1050-c (Published 30 October 2003)
Cite this as: BMJ 2003;327:1050.4

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Alfonso Carvajal (carvajal@ife.uva.es), professor of pharmacology,
  2. Miguel Angel Maciá, clinical pharmacologist,
  3. Javier García del Pozo, pharmacist,
  4. Francisco de Abajo, head
  1. Instituto de Farmacoepidemiología, Ramán y Cajal, 7, E-47005 Valladolid, Spain
  2. Pharmacovigilance Centre of Castilla-La Mancha, Toledo, Spain
  3. Spanish Medicines Agency, Madrid, Spain

    EDITOR—Traversa et al studied the hepatoxicity of nimesulide and other nonsteroidal anti-inflammatory drugs (NSAIDs).1 Nimesulide may arguably have a small risk of the more severe hepatic injuries with an odds ratio of 1.9 (95% confidence interval 1.1 to 3.81). Since the drug is widely used in Italy the population attributable risk could account …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Latest comments and most commented

    THIS WEEK'S POLL

    Read related article

    See previous polls